NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of carbohydrate-based targeted therapeutic compounds to treat cancers and fibrosis, today named Dr. Gilbert S. Omenn to its Scientific Advisory Board.
NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (OTCBB: PRWP), a developer of carbohydrate-based targeted therapeutic compounds to treat cancers and fibrosis, today named Dr. Gilbert S. Omenn to its Scientific Advisory Board.
